<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/2072-0351-5385</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-5385</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Отечественный опыт применения аналога инсулина короткого действия Хумалог у детей и подростков</article-title><trans-title-group xml:lang="en"><trans-title>Otechestvennyy opyt primeneniya analoga insulina korotkogo deystviya Khumalog u detey i podrostkov</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волеводз</surname><given-names>Наталья Никитична</given-names></name><name name-style="western" xml:lang="en"><surname>Volevodz</surname><given-names>Natalya Nikitichna</given-names></name></name-alternatives><email xlink:type="simple">-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кураева</surname><given-names>Тамара Леонидовна</given-names></name><name name-style="western" xml:lang="en"><surname>Kuraeva</surname><given-names>Tamara Leonidovna</given-names></name></name-alternatives><email xlink:type="simple">-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Емельянов</surname><given-names>Андрей Олегович</given-names></name><name name-style="western" xml:lang="en"><surname>Emel'yanov</surname><given-names>Andrey Olegovich</given-names></name></name-alternatives><email xlink:type="simple">-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петеркова</surname><given-names>Валентина Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Peterkova</surname><given-names>Valentina Alexandrovna</given-names></name></name-alternatives><email xlink:type="simple">-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГУ Эндокринологический научный центр, Москва</institution></aff><aff xml:lang="en"><institution>Endocrinology Research Centre, Moscow</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>15</day><month>03</month><year>2006</year></pub-date><volume>9</volume><issue>1</issue><issue-title>№1 (2006)</issue-title><fpage>67</fpage><lpage>70</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Волеводз Н.Н., Кураева Т.Л., Емельянов А.О., Петеркова В.А., 2006</copyright-statement><copyright-year>2006</copyright-year><copyright-holder xml:lang="ru">Волеводз Н.Н., Кураева Т.Л., Емельянов А.О., Петеркова В.А.</copyright-holder><copyright-holder xml:lang="en">Volevodz N.N., Kuraeva T.L., Emel'yanov A.O., Peterkova V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/5385">https://www.dia-endojournals.ru/jour/article/view/5385</self-uri><abstract><p>С применением инсулина ультракороткого действия Хумалог у пациентов появилась возможность более гибко регулировать режим инсулинотерапии, упростить планирование режима и характера питания, физической активности. Важным преимуществом Хумалога является возможность введения после еды, что делает его незаменинмым при инсулинотерапии у маленьких детей. Использование Хумалога у детей и подростков, больных с СД 1 типа, позволяет у многих пациентов достигать целевых уровней компенсации углеводного обмена.</p></abstract><kwd-group xml:lang="ru"><kwd>аналоги инсулина</kwd><kwd>Хумалог</kwd><kwd>дети и подростки</kwd><kwd>сахарный диабет 1 типа</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Анциферов М.Б., Майоров А.Ю. // Реферативный сборник «Ново- сти науки и техники». Серия Медицина. Вып. «Клиническая эндокри- нология», М., ВИНИТИ, 1997. - №7. - С.8.</mixed-citation><mixed-citation xml:lang="en">Анциферов М.Б., Майоров А.Ю. // Реферативный сборник «Ново- сти науки и техники». Серия Медицина. Вып. «Клиническая эндокри- нология», М., ВИНИТИ, 1997. - №7. - С.8.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Анциферов М.Б., Майоров А.Ю., Ристич С., Дедов И.И. // Клиничес- кая фармакология и терапия. - 1997. - №1. - С. 68-70.</mixed-citation><mixed-citation xml:lang="en">Анциферов М.Б., Майоров А.Ю., Ристич С., Дедов И.И. // Клиничес- кая фармакология и терапия. - 1997. - №1. - С. 68-70.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И,, Кураева Т.Л.., Петеркова В.А., Щербачева Л.Н. «Сахар- ный диабет у детей и подростков».- М., Универсум Паблишинг, 2002.</mixed-citation><mixed-citation xml:lang="en">Дедов И.И,, Кураева Т.Л.., Петеркова В.А., Щербачева Л.Н. «Сахар- ный диабет у детей и подростков».- М., Универсум Паблишинг, 2002.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Петеркова В.А., Волеводз Н.Н. Инсулин ультракороткого действия «Хумалог» в лечении сахарного диабета 1 типа у детей и подростков. Методические рекомендации (№13). М. 2001.</mixed-citation><mixed-citation xml:lang="en">Дедов И.И., Петеркова В.А., Волеводз Н.Н. Инсулин ультракороткого действия «Хумалог» в лечении сахарного диабета 1 типа у детей и подростков. Методические рекомендации (№13). М. 2001.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Петеркова В.А., Волеводз Н.Н., Щербачева Л.Н., Кураева Т.Л. «Опыт применения различных режимов введения инсулина ультракороткого действия, хумалога, у детей». // Реферативный сборник «Новости науки и техники».Серия Медицина. Вып. «Клиническая эндокринология», М., ВИНИТИ, 2000. - №5. - С.7-10.</mixed-citation><mixed-citation xml:lang="en">Петеркова В.А., Волеводз Н.Н., Щербачева Л.Н., Кураева Т.Л. «Опыт применения различных режимов введения инсулина ультракороткого действия, хумалога, у детей». // Реферативный сборник «Новости науки и техники».Серия Медицина. Вып. «Клиническая эндокринология», М., ВИНИТИ, 2000. - №5. - С.7-10.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson J.H., Brunelle R.L. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin analog treatment. // Diabetes. - 1997. - Vol.46. - P. 265-270.</mixed-citation><mixed-citation xml:lang="en">Anderson J.H., Brunelle R.L. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin analog treatment. // Diabetes. - 1997. - Vol.46. - P. 265-270.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Deeb L.C., Holcome J.H., Brunelle R.L. Insulin lispro lowers postprandial glucose in prepubertal children with diabetes. // Pediatrics 2001; 108 (5): 1175-1179.</mixed-citation><mixed-citation xml:lang="en">Deeb L.C., Holcome J.H., Brunelle R.L. Insulin lispro lowers postprandial glucose in prepubertal children with diabetes. // Pediatrics 2001; 108 (5): 1175-1179.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Diabetes Control and Comlications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term comlications in insulin-dependent diabetes mellitus. // N Engl J Med. 1993; 329: 997-986.</mixed-citation><mixed-citation xml:lang="en">Diabetes Control and Comlications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term comlications in insulin-dependent diabetes mellitus. // N Engl J Med. 1993; 329: 997-986.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">DiMarchi R.D., Chance R.E. Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of the structural homology with insulin-like growth factor I. // Horm. Res. - 1994. - Vol. 41 [Suppl 2]. - P. 93-96.</mixed-citation><mixed-citation xml:lang="en">DiMarchi R.D., Chance R.E. Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of the structural homology with insulin-like growth factor I. // Horm. Res. - 1994. - Vol. 41 [Suppl 2]. - P. 93-96.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Garg S.K., Carmain J.A. Premeal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes. // Diabet. Med. - 1996. - Vol. 13. - P.47-52.</mixed-citation><mixed-citation xml:lang="en">Garg S.K., Carmain J.A. Premeal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes. // Diabet. Med. - 1996. - Vol. 13. - P.47-52.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Heinemann L., Heise T., Wahl C. Prandial glycemia after carbohydrate rich meal in Type 1 diabetic patients: using the rapid acting insulin analog [Lys(b28), Pro(b29) human insulin. // Diabet Med. - 1996. - Vol. 13. - P.625-629.</mixed-citation><mixed-citation xml:lang="en">Heinemann L., Heise T., Wahl C. Prandial glycemia after carbohydrate rich meal in Type 1 diabetic patients: using the rapid acting insulin analog [Lys(b28), Pro(b29) human insulin. // Diabet Med. - 1996. - Vol. 13. - P.625-629.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Holcombe J.H., Zalani S, Arora V. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents. //Clin Ther 2002; 24(4): 629-638.</mixed-citation><mixed-citation xml:lang="en">Holcombe J.H., Zalani S, Arora V. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents. //Clin Ther 2002; 24(4): 629-638.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Howey D.C, Bowsher R.R., Brunelle R.L., Lys(B28), Pro(B29)-human insulin: a rapidly absorbed analogue of human insulin. // Diabetes.- 1994. - Vol.43. - P. 396-402.</mixed-citation><mixed-citation xml:lang="en">Howey D.C, Bowsher R.R., Brunelle R.L., Lys(B28), Pro(B29)-human insulin: a rapidly absorbed analogue of human insulin. // Diabetes.- 1994. - Vol.43. - P. 396-402.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Jeong U., Kwon E., Kim J. Effects of insulin lispro with pump therapy on blood glucose control and quality of life in children with type 1 diabetes mellitus. //Diabetes 2001; 50 (suppl 2): A 421.</mixed-citation><mixed-citation xml:lang="en">Jeong U., Kwon E., Kim J. Effects of insulin lispro with pump therapy on blood glucose control and quality of life in children with type 1 diabetes mellitus. //Diabetes 2001; 50 (suppl 2): A 421.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kaufmann F., Halvorson M., Kim C. Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. // Diabetes Care 2000; 23 (5): 579-582.</mixed-citation><mixed-citation xml:lang="en">Kaufmann F., Halvorson M., Kim C. Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. // Diabetes Care 2000; 23 (5): 579-582.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lalli C, Ciofetta M, Del Sindaco P. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combinations with NPH insulin at mealtime. // Diabetes Care 1999; 22: 468-477.</mixed-citation><mixed-citation xml:lang="en">Lalli C, Ciofetta M, Del Sindaco P. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combinations with NPH insulin at mealtime. // Diabetes Care 1999; 22: 468-477.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Litton RN, Rice A. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. // Eur J Pediatr 2002; 141: 490-495.</mixed-citation><mixed-citation xml:lang="en">Litton RN, Rice A. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. // Eur J Pediatr 2002; 141: 490-495.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rami B, Schober E. Postprandial glycaemia after regular and lispro insulin in children and adolescents with diabetes. // Eur J Pediatr 1997; 156: 838-840.</mixed-citation><mixed-citation xml:lang="en">Rami B, Schober E. Postprandial glycaemia after regular and lispro insulin in children and adolescents with diabetes. // Eur J Pediatr 1997; 156: 838-840.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Rutledge K.S., Chase H.P., Klingensmith GJ. Effectiveness of postprandial Humalog in toddlers with diabetes. // Pediatrics 1997; 100 (6): 968-972.</mixed-citation><mixed-citation xml:lang="en">Rutledge K.S., Chase H.P., Klingensmith GJ. Effectiveness of postprandial Humalog in toddlers with diabetes. // Pediatrics 1997; 100 (6): 968-972.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Tamborlane WV, Ahern J. Implications and results of the diabetes control and complications trial. // Pediatr Clin North Am 1997; 44(2):285-300.</mixed-citation><mixed-citation xml:lang="en">Tamborlane WV, Ahern J. Implications and results of the diabetes control and complications trial. // Pediatr Clin North Am 1997; 44(2):285-300.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Tubiana-Rufi N, Coutand R., Efficacy and tolerance of insulin lispro in young diabetic children treated with CSII. // Diabetologia 2000; 43 (suppl): A 199.</mixed-citation><mixed-citation xml:lang="en">Tubiana-Rufi N, Coutand R., Efficacy and tolerance of insulin lispro in young diabetic children treated with CSII. // Diabetologia 2000; 43 (suppl): A 199.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Tupola S, Komulainen J. Post-prandial insulin lispro vs. human regular insulin in prepubertal children with type 1 diabetes mellitus. // Diabet Med 2001; 18 (8): 654-658.</mixed-citation><mixed-citation xml:lang="en">Tupola S, Komulainen J. Post-prandial insulin lispro vs. human regular insulin in prepubertal children with type 1 diabetes mellitus. // Diabet Med 2001; 18 (8): 654-658.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Volevodz N.N., Sherbacheva L.N., Kouraeva T.L., Peterkova V.A. Effectiveness pre- versus postprandial Insulin Lispro in Young Children with Insulin-Dependent Diabetes Mellitus (IDDM). // Diabetologia. - 2000. -(Supp1) A 200.</mixed-citation><mixed-citation xml:lang="en">Volevodz N.N., Sherbacheva L.N., Kouraeva T.L., Peterkova V.A. Effectiveness pre- versus postprandial Insulin Lispro in Young Children with Insulin-Dependent Diabetes Mellitus (IDDM). // Diabetologia. - 2000. -(Supp1) A 200.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">William V. Tamborlane, J Ahern. Insulin therapy in children.</mixed-citation><mixed-citation xml:lang="en">William V. Tamborlane, J Ahern. Insulin therapy in children.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
